Biological

SV-BR-1-GM clinical trials

studies test it: 3
open now: 1
in phase 3: 1
first study started: 2017

Keep track of what changes. Save the SV-BR-1-GM studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

SV-BR-1-GM: 3

Studies by the year they started

3 studies that test it; most in 2017 (1)

Studies that test SV-BR-1-GM, by start year
Year	Studies
2017	1
2018	1
2023	1

By phase

A phase 1/2 study counts in both.

Phase 1: 2
Phase 2: 2
Phase 3: 1

What it is tested for

Each study’s main condition, where its own words name it.

Breast Neoplasms: 3

Who runs them

Industry 3 · Other 0

BriaCell Therapeutics Corporation (3)

Often tested with

Tested in the same studies.

Retifanlimab (2) · Cyclophosphamide (1)

Studies

Open first, then newest update. How each study uses SV-BR-1-GM is read from its arms, and is right about nine times in ten.

Testing it · 3

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.RecruitingPhase 3BriaCell Therapeutics CorporationNCT06072612Written as SV-BR-1-GM
Combination Study of SV-BR-1-GM With RetifanlimabCompletedPhase 1/2BriaCell Therapeutics CorporationNCT03328026Written as SV-BR-1-GM
SV-BR-1-GM in Metastatic or Locally Recurrent Breast CancerCompletedPhase 1/2BriaCell Therapeutics CorporationNCT03066947Written as SV-BR-1-GM